Publications

BibTex format

@article{Berlanga:2020:10.1186/s12916-020-01817-1,
author = {Berlanga, A and Cupp, M and Tzoulaki, I and Evangelou, E and Aune, D and Cariolou, M},
doi = {10.1186/s12916-020-01817-1},
journal = {BMC Medicine},
title = {Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies},
url = {http://dx.doi.org/10.1186/s12916-020-01817-1},
volume = {18},
year = {2020}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BackgroundAlthough neutrophils have been linked to the progression of cancer, uncertainty exists around their association with cancer outcomes, depending on the site, outcome and treatments considered. We aimed to evaluate the strength and validity of evidence on the association between either the neutrophil to lymphocyte ratio (NLR) or tumour-associated neutrophils (TAN) and cancer prognosis.MethodsWe searched MEDLINE, Embase and Cochrane Database of Systematic Reviews from inception to 29 May 2020 for systematic reviews and meta-analyses of observational studies on neutrophil counts (here NLR or TAN) and specific cancer outcomes related to disease progression or survival. The available evidence was graded as strong, highly suggestive, suggestive, weak or uncertain through the application of pre-set GRADE criteria.ResultsA total of 204 meta-analyses from 86 studies investigating the association between either NLR or TAN and cancer outcomes met the criteria for inclusion. All but one meta-analyses found a hazard ratio (HR) which increased risk (HR > 1). We did not find sufficient meta-analyses to evaluate TAN and cancer outcomes (N = 9). When assessed for magnitude of effect, significance and bias related to heterogeneity and small study effects, 18 (9%) associations between NLR and outcomes in composite cancer endpoints (combined analysis), cancers treated with immunotherapy and some site specific cancers (urinary, nasopharyngeal, gastric, breast, endometrial, soft tissue sarcoma and hepatocellular cancers) were supported by strong evidence.ConclusionIn total, 60 (29%) meta-analyses presented strong or highly suggestive evidence. Although the NLR and TAN hold clinical promise in their association with poor cancer prognosis, further research is required to provide robust evidence, assess causality and test clinical utility.
AU  - Berlanga,A
AU  - Cupp,M
AU  - Tzoulaki,I
AU  - Evangelou,E
AU  - Aune,D
AU  - Cariolou,M
DO  - 10.1186/s12916-020-01817-1
PY  - 2020///
SN  - 1741-7015
TI  - Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies
T2  - BMC Medicine
UR  - http://dx.doi.org/10.1186/s12916-020-01817-1
UR  - http://hdl.handle.net/10044/1/84822
VL  - 18
ER  -

Download

DrDagfinnAune

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)